Reports
Sale
Australia and New Zealand Ultrasound Devices Market Size: By Type: Stationary Ultrasound, Portable Ultrasound; By Technology: 2D Ultrasound Imaging, 3D and 4D Ultrasound Imaging, Doppler Imaging, High-intensity Focused Ultrasound; By Applications; By Portability; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Australia and New Zealand Ultrasound Devices Market Outlook
The Australia and New Zealand ultrasound devices market size is anticipated to grow at a CAGR of 6.07% during the forecast period of 2024-2032, driven by the increasing prevalence of cardiovascular diseases across the globe.
Australia and New Zealand Ultrasound Devices Market Overview
The growth of the market is being driven by the advancements in medical technology and increasing healthcare awareness. This dynamic market is witnessing a rising demand for cutting-edge ultrasound devices, including portable and 3D/4D imaging systems. The regions’ healthcare infrastructure development, coupled with a growing elderly population, contributes to the expanding market. Additionally, the emphasis on early disease detection and prenatal care fuels the adoption of ultrasound technology. The Australia and New Zealand ultrasound devices market growth is also driven by the growing burden of chronic diseases, like cardiovascular diseases and cancer, along with increased healthcare investments and technological advancements.
According to According to the cancer data in Australia, there were approximately 3,830 new cases of thyroid cancer diagnosed in Australia, with 1,070 cases in males and 2,760 in females. The report also indicates that the likelihood of being diagnosed with thyroid cancer by the age of 85 is projected to be 1 in 83 (1.2%), with specific probabilities for males (1 in 145 or 0.69%) and females (1 in 58 or 1.7%). Ultrasound, being a convenient and widely available imaging modality that does not involve ionizing radiation, is considered ideal for detecting and evaluating thyroid nodules. Consequently, the increasing incidence of thyroid cancer in the country is expected to drive the Australia and New Zealand ultrasound devices market demand.
Increasing Funding by the Government Strengthens Imaging Services
The Australian Government's augmented financial support for enhancing imaging services is anticipated to fuel the market expansion. The government allocated additional funds for the expansion of the Heart of Australia Program in April 2022, amounting to approximately USD 12.0 million. This program extends mobile medical clinic services throughout northern Queensland, offering heart monitoring and various healthcare services. The government's commitment to cardiovascular care delivery is expected to boost the demand for ultrasound equipment, contributing to the Australia and New Zealand ultrasound devices market share.
Increasing Usage of High-intensity Focused Ultrasound Source
High-intensity focused ultrasound is increasingly employed in the treatment of both primary and metastatic tumors due to its precise tumor identification capabilities during ablation. In cases where patients exhibit substantial medical co-morbidities, rendering them high-risk candidates for surgery, or possess lower liver function restricting hepatectomy, high-intensity focused ultrasound emerges as a viable therapeutic option for addressing liver tumors. High-intensity focused ultrasound emerges as a promising and safe alternative for the minimally invasive treatment of localized prostate cancer.
Notably, recent research published by the Mayo Foundation in August underscores the growing interest in mitigating treatment-related side effects associated with prostate cancer by targeting a specific portion of the affected prostate. Focal therapy, utilizing high-intensity focused ultrasound (HIFU), proves effective in addressing this concern. HIFU precisely targets the most aggressive tumor, sparing the surrounding prostate structures. This approach is widely accepted in treating various cancers, including kidney cancers, where only the tumor is removed or ablated, leaving the rest of the organ intact. Consequently, the increased demand for HIFU systems may drive their adoption in Australian healthcare for minimally invasive prostate cancer treatment.
Australia and New Zealand Ultrasound Devices Market Segmentations
Market Breakup by Type
- Stationary Ultrasound
- Portable Ultrasound
Market Breakup by Technology
- Advanced2D Ultrasound Imaging
- 3D and 4D Ultrasound Imaging
- Doppler Imaging
- High-intensity Focused Ultrasound
Market Breakup by Applications
- Anesthesiology
- Cardiology
- Gynecology/Obstetrics
- Musculoskeletal
- Radiology
- Primary Care
- Critical Care
- Emergency Medicine
Market Breakup by Portability
- Handheld
- Compact
- Cart/Trolley
- Point-of-Care Cart/Trolley Based Ultrasound
- Higher-end Cart/Trolley Based Ultrasound
Market Breakup by End User
- Hospitals
- Imaging Centres
- Research Centres
Market Breakup by Country
- Australia
- New Zealand
Australia and New Zealand Ultrasound Devices Market: Competitor Landscape
The ultrasound devices market in Australia and New Zealand exhibits a moderate level of competitiveness, with prominent players. Key market leaders include Mindray Medical International Limited, Siemens Healthineers AG, GE Healthcare, Fujifilm Holdings Corporation, and Koninklijke Philips NV, among others.
In November 2022, Caption Health disclosed the receipt of regulatory approvals from Health Canada's Medical Devices Directorate and Australia's Therapeutic Goods Administration to market its Caption AI technology platform. This innovative platform enables healthcare professionals in Australia and Canada, regardless of prior sonography experience, to conduct cardiac ultrasounds.
The key features of the Australia and New Zealand ultrasound devices market report includes patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
The major companies in the market are as follows:
- Canon Medical Systems Corporation
- SonoScape Medical Corp
- Fujifilm Holdings Corporation
- GE Healthcare
- Hologic Inc.
- Koninklijke Philips NV
- Mindray Medical International Limited
- Samsung Electronics Co. Ltd.
- Esaote SPA
- Siemens Healthineers AG
- ALPINION MEDICAL SYSTEMS Co., Ltd.
- CHISON Medical Technologies Co., Ltd.
- SAMSUNG HEALTHCARE
- Analogic Corporation
- General Electric
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Technology |
|
| Breakup by Applications |
|
| Breakup by Portability |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Australia and New Zealand Ultrasound Devices Market Overview
3.1 Australia and New Zealand Ultrasound Devices Market Historical Value (2017-2023)
3.2 Australia and New Zealand Ultrasound Devices Market Forecast Value (2024-2032)
4 Australia and New Zealand Ultrasound Devices Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Australia and New Zealand Ultrasound Devices Market Segmentation
5.1 Australia and New Zealand Ultrasound Devices Market by Type
5.1.1 Market Overview
5.1.2 Stationary Ultrasound
5.1.3 Portable Ultrasound
5.2 Australia and New Zealand Ultrasound Devices Market by Technology
5.2.1 Market Overview
5.2.2 2D Ultrasound Imaging
5.2.3 3D and 4D Ultrasound Imaging
5.2.4 Doppler Imaging
5.2.5 High-intensity Focused Ultrasound
5.3 Australia and New Zealand Ultrasound Devices Market by Applications
5.3.1 Market Overview
5.3.2 Anesthesiology
5.3.3 Cardiology
5.3.4 Gynecology/Obstetrics
5.3.5 Musculoskeletal
5.3.6 Radiology
5.3.7 Primary Care
5.3.8 Critical Care
5.3.9 Emergency Medicine
5.4 Australia and New Zealand Ultrasound Devices Market by Portability
5.4.1 Market Overview
5.4.2 Handheld
5.4.3 Compact
5.4.4 Cart/Trolley
5.4.4.1 Point-of-Care Cart/Trolley Based Ultrasound
5.4.4.2 Higher-end Cart/Trolley Based Ultrasound
5.5 Australia and New Zealand Ultrasound Devices Market by End User
5.5.1 Market Overview
5.5.2 Hospitals
5.5.3 Imaging Centres
5.5.4 Research Centres
5.6 Australia and New Zealand Ultrasound Devices Market by Country
5.6.1 Market Overview
5.6.2 Australia
5.6.3 New Zealand
6 Patent Analysis
6.1 Analysis by Type of Patent
6.2 Analysis by Publication year
6.3 Analysis by Issuing Authority
6.4 Analysis by Patent Age
6.5 Analysis by CPC Analysis
6.6 Analysis by Patent Valuation
6.7 Analysis by Key Players
7 Grants Analysis
7.1 Analysis by year
7.2 Analysis by Amount Awarded
7.3 Analysis by Issuing Authority
7.4 Analysis by Grant Application
7.5 Analysis by Funding Institute
7.6 Analysis by NIH Departments
7.7 Analysis by Recipient Organization
8 Funding Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Partnership and Collaborations Analysis
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Partnership
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Regulatory Framework
10.1 Regulatory Overview
11 Supplier Landscape
11.1 Canon Medical Systems Corporation
11.1.1 Financial Analysis
11.1.2 Product Portfolio
11.1.3 Demographic Reach and Achievements
11.1.4 Mergers and Acquisitions
11.1.5 Certifications
11.2 SonoScape Medical Corp
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Mergers and Acquisitions
11.2.5 Certifications
11.3 Fujifilm Holdings Corporation
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Mergers and Acquisitions
11.3.5 Certifications
11.4 GE Healthcare
11.4.1 Financial Analysis
11.4.2 Financial Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Mergers and Acquisitions
11.4.5 Certifications
11.5 Hologic Inc.
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Mergers and Acquisitions
11.5.5 Certifications
11.6 Koninklijke Philips NV
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Mergers and Acquisitions
11.6.5 Certifications
11.7 Mindray Medical International Limited
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Mergers and Acquisitions
11.7.5 Certifications
11.8 Samsung Electronics Co. Ltd.
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Mergers and Acquisitions
11.8.5 Certifications
11.9 Esaote SPA
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Mergers and Acquisitions
11.9.5 Certifications
11.10 Siemens Healthineers AG
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Mergers and Acquisitions
11.10.5 Certifications
11.11 ALPINION MEDICAL SYSTEMS Co., Ltd.
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Mergers and Acquisitions
11.11.5 Certifications
11.12 CHISON Medical Technologies Co., Ltd.
11.12.1 Financial Analysis
11.12.2 Product Portfolio
11.12.3 Demographic Reach and Achievements
11.12.4 Mergers and Acquisitions
11.12.5 Certifications
11.13 SAMSUNG HEALTHCARE
11.13.1 Financial Analysis
11.13.2 Product Portfolio
11.13.3 Demographic Reach and Achievements
11.13.4 Mergers and Acquisitions
11.13.5 Certifications
11.14 Analogic Corporation
11.14.1 Financial Analysis
11.14.2 Product Portfolio
11.14.3 Demographic Reach and Achievements
11.14.4 Mergers and Acquisitions
11.14.5 Certifications
11.15 General Electric
11.15.1 Financial Analysis
11.15.2 Product Portfolio
11.15.3 Demographic Reach and Achievements
11.15.4 Mergers and Acquisitions
11.15.5 Certifications
12 Australia and New Zealand Ultrasound Devices Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
14 Company Competitiveness Analysis (Additional Insight)
14.1 Very Small Companies
14.2 Small Companies
14.3 Mid-Sized Companies
14.4 Large Companies
14.5 Very Large Companies
15 Payment Methods (Additional Insight)
15.1 Government Funded
15.2 Private Insurance
15.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 6.07% during the forecast period of 2024-2032.
The market demand is driven by the increasing burden of chronic diseases such as cardiovascular diseases and cancer, coupled with the rising healthcare investment in the country and technological advancements.
The current market trend involves the rising support from the government in the form of initiatives and investments in ultrasound devices.
It is commonly divided into stationary ultrasound and portable ultrasound.
Treatment types include advanced 2D ultrasound imaging, 3D and 4D ultrasound imaging, doppler imaging, and high-intensity focused ultrasoundand.
Major applications are anesthesiology, cardiology, gynecology/obstetrics, musculoskeletal, radiology, primary care, critical care, and emergency medicine.
The segments can be divided into handheld, compact, and cart/trolley.
Major end users include hospitals, imaging centres, and research centres.
The key players in the market include Canon Medical Systems Corporation, SonoScape Medical Corp, Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips NV, Mindray Medical International Limited, Samsung Electronics Co. Ltd., Esaote SPA, Siemens Healthineers AG, ALPINION MEDICAL SYSTEMS Co., Ltd., CHISON Medical Technologies Co., Ltd., SAMSUNG HEALTHCARE, Analogic Corporation, and General Electric.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER